|
|
|
|
|
|
|
Free Newsletters
Archive
My Subscriptions
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers
Regional News
US & Canada
Biotech Bay
Biotech Beach
Genetown
Pharm Country
BioCapital
BioMidwest
Bio NC
BioForest
Southern Pharm
BioCanada East
US Device
Europe
Asia
Market Summary
News
IPOs
Company Profiles
Companies
Events
Research Store
Biotech Events
Post an Event
Real Estate
Business Opportunities
|
|
|
|
|
News | News By Subject | News by Disease |
News By Date | Search News
|
|
|
Tranzyme Pharma (TZYM) to Present at the Canaccord Genuity 32nd Annual Growth Conference on August 14, 2012
8/1/2012 9:36:40 AM
RESEARCH TRIANGLE PARK, N.C., Aug. 1, 2012 (GLOBE NEWSWIRE) -- Tranzyme Pharma (Nasdaq:TZYM), today announced that Vipin K. Garg, Ph.D., President and CEO, and Richard I. Eisenstadt, Vice President, Finance and CFO, will present at the Canaccord Genuity 32nd Annual Growth Conference taking place at the Intercontinental Hotel in Boston, MA August 14-16, 2012. Tranzyme's presentation is scheduled for Tuesday, August 14th at 1:00 pm ET in the Vancouver Room followed by a breakout session.
|
|
|
|
|
|
|
|
|
|
|